The use of pERM as a marker for ROCK activity in DLBCL cell lines was first validated by intracellular FACS as demonstrated by the finding that the high levels of pERM were significantly decreased following knockdown of ROCK1 or ROCK2 (Fig. S5A). Here, ROCK1 is linked to diffuse large B-cell lymphoma.